Entity usage

From MaRDI portal

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 50 results in range #201 to #250.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Measuring uncertainty in complex decision analysis models: Label: en
  2. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section: Label: en
  3. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies: Label: en
  4. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods: Label: en
  5. Ethical issues in oncology biostatistics: Label: en
  6. Placebos that harm: sham surgery controls in clinical trials: Label: en
  7. Ethical considerations concerning treatment allocation in drug development trials: Label: en
  8. Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go?: Label: en
  9. The ethics of consulting for the tobacco industry: Label: en
  10. On the ethical aspects of the testimony of statisticians in court: Label: en
  11. Analysis of repeated measures data with clumping at zero: Label: en
  12. Inferences about population means of health care costs: Label: en
  13. Mixture models for quantitative HIV RNA data: Label: en
  14. Repeated measures with zeros: Label: en
  15. Analysis of data with excess zeros: Label: en
  16. Added value of three-way methods for the analysis of mortality trends illustrated with worldwide female cancer mortality (1968-1985): Label: en
  17. Partitioning and peeling for constructing prognostic groups: Label: en
  18. Techniques for incorporating longitudinal measurements into analyses of survival data from clinical trials: Label: en
  19. Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials: Label: en
  20. Competing risks as a multi-state model: Label: en
  21. Estimation of covariate-dependent Markov transition probabilities from nested case-control data: Label: en
  22. Inference for multi-state models from interval-censored data: Label: en
  23. Analysis of repeated events: Label: en
  24. Multi-state models for bone marrow transplantation studies: Label: en
  25. Multi-state models for event history analysis: Label: en
  26. Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups: Label: en
  27. The analysis of repeated multivariate binary quality of life data: a hierarchical model approach: Label: en
  28. A review of ordinal regression models applied on health-related quality of life assessments: Label: en
  29. Simultaneous analysis of quality of life and survival data: Label: en
  30. Analysing longitudinal continuous quality of life data with dropout: Label: en
  31. Multilevel analysis with messy data: Label: en
  32. Multilevel models for censored and latent responses: Label: en
  33. Estimating effects of latent and measured genotypes in multilevel models: Label: en
  34. Multilevel models for meta-analysis, and their application to absolute risk differences: Label: en
  35. Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress: Label: en
  36. Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients: Label: en
  37. Statistical methods for the meta-analysis of cluster randomization trials: Label: en
  38. An asymptotically unbiased estimator of exposed versus non-exposed odds ratio from reported dose-response data: Label: en
  39. Bayesian methods in meta-analysis and evidence synthesis: Label: en
  40. Approximations for trimmed Fisher procedures in research synthesis: Label: en
  41. A sensitivity analysis for publication bias in systematic reviews: Label: en
  42. The application of methods to quantify attributable risk in medical practice: Label: en
  43. Partitioning methods for multifactorial risk attribution: Label: en
  44. A review of adjusted estimators of attributable risk: Label: en
  45. Attributable fractions: fundamental concepts and their visualization: Label: en
  46. Mathematical biology and medical statistics: contributions to the understanding of AIDS epidemiology: Label: en
  47. Advances in medical statistics arising from the AIDS epidemic: Label: en
  48. Random effects models for HIV marker data: practical approaches with currently available software: Label: en
  49. Statistical advances in AIDS therapy trials: Label: en
  50. A chronology of fine-scale gene mapping by linkage disequilibrium: Label: en

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://portal.mardi4nfdi.de/wiki/Special:EntityUsage/Q62028"
Powered by MediaWiki